Violation Tracker Individual Record
Company:Reckitt Benckiser Group plc
Date:July 11, 2019
Primary Offense:Controlled Substances Act violation
Secondary Offense:False Claims Act and related
Reckitt Benckiser Group PLC agreed to pay more than $1.3 billion to resolve its potential criminal and civil liability related to a federal investigation of the marketing of the opioid addiction treatment drug Suboxone.
Level of Government:federal
Action Type:agency action
Agency:U.S. Attorney-Western District of Virginia
Civil or Criminal Case:civil and criminal
Prosecution Agreement:non-prosecution agreement
HQ Country of Parent:Britain
Ownership Structure of Parent:publicly traded
Major Industry of Parent:household and personal care products
Specific Industry of Parent:personal care products
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.